Top Markets
#1 Fake World Assets Fake World Assets +12.13%
#2 B3 (Base) B3 (Base) +7.21%
#3 OriginTrail OriginTrail +5.67%
#4 BasedHype BasedHype +5.04%
#5 Ontology Ontology +3.60%
#6 Dual Dual +3.59%
#7 Audiera Audiera +3.29%
#8 COTI COTI +3.23%
#9 Strategy PP Variable xStock Strategy PP Variable xStock +3.04%
#10 MVL MVL +2.41%
Coin of the day
Fake World Assets Fake World Assets
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
SynAct Pharma AB SynAct Pharma AB

SynAct Pharma AB

SYNACT
Classifica tra le azioni #20988
SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS,... SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS, specializes in creating pharmaceutical interventions for the acute exacerbation of inflammatory conditions. The company's primary investigational compound, AP1189, is currently being developed for the treatment of both rheumatoid arthritis and idiopathic membranous glomerulonephritis. Additionally, SynAct Pharma maintains a collaborative research initiative with the University of Örebro, focusing on the mitigation of inflammation in vascular diseases. Established in 2012, the firm's corporate headquarters are situated in Lund, Sweden.
Prezzo delle azioni
$2.22
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$117.70M
Variazione (1 giorno)
2.69%
Variazione (1 anno)
17.26%
Paese
SE
Scambia SynAct Pharma AB (SYNACT)

Categoria

Healthcare
Rapporto P/S per SynAct Pharma AB (SYNACT)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di SynAct Pharma AB, il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per SynAct Pharma AB da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH